{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:03:08Z","timestamp":1792519388266,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004293.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000}}],"reference-count":238,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004293.pub4","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T08:41:56Z","timestamp":1636965716000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome"],"prefix":"10.1002","volume":"2021","author":[{"given":"Thilo C","family":"von Groote","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care and Pain Medicine; University Hosptial M\u00fcnster; M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Williams","sequence":"additional","affiliation":[{"name":"Analytics Assist; NSW Ministry of Health; North Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H","family":"Au","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"},{"name":"Department of Renal Medicine; Westmead Hospital; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hainan Hospital of Chinese PLA General Hospital; Hainan Provincial Academician Team Innovation Center; Sanya China"},{"name":"Senior Department of Nephrology, the First Medical Center of Chinese PLA General Hospital; Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research; Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T","family":"Mathew","sequence":"additional","affiliation":[{"name":"Department of Nephrology; McMaster University; Hamilton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Tunnicliffe","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0001|cit1","first-page":"719A","article-title":"Prospective study to compare efficacy of tacrolimus versus cyclophosphamide in inducing remission in idiopathic membranous nephropathy [abstract no: SA-PO357]","volume":"23","author":"Agarwal","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0002|cit2","first-page":"51","article-title":"Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study","volume":"13","author":"Ahmed","year":"1994","journal-title":"Bangladesh Renal Journal"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0003|cit3","unstructured":"Rahman M Ahmed S Alam MR Selim SI Chowdhury MN Chowdhury SM Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 66"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0004|cit4","first-page":"668A","article-title":"Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy (IMN): preliminary baseline and pharmacokinetic (PK)\/pharmacodynamic (PD) data [abstract no: SU-PO970]","volume":"13","author":"Appel","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0005|cit5","first-page":"122A","article-title":"Lipoprotein-(a)[Lp(a)] levels in nephrotic syndrome [NS] [abstract no: A0642]","volume":"12","author":"Radhakrishnan","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0006|cit6","first-page":"571A","article-title":"A randomized study on treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy [abstract no: F-PO1112]","volume":"17","author":"Arnadottir","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub4-BIB0007|cit7","first-page":"1327","article-title":"Randomized trial of pulse cyclophosphamide and prednisone vs. prednisone alone in idiopathic membranous nephropathy [abstract no: A0410]","volume":"7","author":"Austin","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0008|cit8","unstructured":"Braun N Dietz K Vonthein R Erley C Risler T Remission and relapses in idiopathic membranous nephropathy. Description by a longitudinal multi-state Markov-model [abstract no: SP054] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 34 5"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0009|cit9","first-page":"413","article-title":"Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 years follow-up of a prospective, randomized multi-center study [abstract no: 726]","volume":"6","author":"Braun","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0010|cit10","first-page":"967","article-title":"Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 years follow-up of a prospective, randomized multi-centre study [abstract]","volume":"10","author":"Braun","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"274","key":"10.1002\/14651858.CD004293.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oxfordjournals.qjmed.a068422","article-title":"The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party","volume":"74","author":"Cameron","year":"1990","journal-title":"Quarterly Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0012|cit12","first-page":"507","article-title":"The MRC trial of prednisolone in membranous nephropathy. The Working Party of the UK MRC Glomerulonephritis Registry [abstract]","volume":"3","author":"Cameron","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0013|cit13","first-page":"844","article-title":"The MRC trial of prednisolone in membranous nephropathy. The Working Party of the MRC Glomerulonephritis Registry [abstract]","volume":"3","author":"Cameron","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0014|cit14","first-page":"600","article-title":"Results of a controlled trial of alternate day prednisone (ADS) in idiopathic membranous glomerulonephritis (IMGN) [abstract]","volume":"27","author":"Cattran","year":"1985","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0015|cit15","first-page":"388","article-title":"Preliminary results of controlled trial of alternate-day prednisone in idiopathic membranous glomerulonephritis [abstract]","volume":"19","author":"Cattran","year":"1981","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0016|cit16","first-page":"208","article-title":"Results of a controlled trial of alternate day prednisone (P) in membranous nephropathy (IMGN) [abstract]","volume":"35","author":"Cattran","year":"1989","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0018|cit18","first-page":"271","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy [abstract no: 118P]","volume":"4","author":"Cattran","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0020|cit20","unstructured":"Cattran DC Cyclosporine in the treatment of membranous nephropathy (MGN) [abstract] 12th International Congress of Nephrology; 1993, Jun 13-18; Jerusalem, Israel 1993 535"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0022|cit22","first-page":"85A","article-title":"Randomized controlled trial of cyclosporine (D) vs placebo (P) in steroid resistant, nephrotic patients (NS) with membranous nephropathy (SR-MGN) [abstract]","volume":"9","author":"Cattran","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0023|cit23","first-page":"7","article-title":"Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathy","volume":"60","author":"Cattran","year":"2003","journal-title":"Clinical Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1440-1797.2007.00822.x","article-title":"Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome","volume":"12","author":"Chan","year":"2007","journal-title":"Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0025|cit25","first-page":"802A","article-title":"A randomized controlled study comparing prednisone plus tacrolimus versus prednisone plus cyclophosphamide in patients with membranous nephropathy and nephrotic syndrome [abstract no: SA-PO1086]","volume":"17","author":"Chen","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181ca3a7d","article-title":"Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial","volume":"339","author":"Chen","year":"2010","journal-title":"American Journal of the Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.ajkd.2013.05.005","article-title":"Efficacy and safety of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial","volume":"62","author":"Chen","year":"2013","journal-title":"American Journal of Kidney Diseases"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0028|cit28","first-page":"61A","article-title":"The effect of mycophenolate mofetil versus cyclosporine as a combination therapy to low dose corticosteroid in high risk patients with idiopathic membranous nephropathy: a multicenter randomized trial [abstract no: FR-OR113]","volume":"27","author":"Choi","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.3346\/jkms.2018.33.e74","article-title":"The effect of mycophenolate mofetil versus cyclosporine as combination therapy with low dose corticosteroids in high-risk patients with idiopathic membranous nephropathy: a multicenter randomized trial","volume":"33","author":"Choi","year":"2018","journal-title":"Journal of Korean Medical Science"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/ki.1980.63","article-title":"Circulating immune complexes in adults with idiopathic nephrotic syndrome. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome","volume":"17","author":"Abrass","year":"1980","journal-title":"Kidney International"},{"issue":"24","key":"10.1002\/14651858.CD004293.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM197912133012401","article-title":"A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome","volume":"301","year":"1979","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0032|cit32","first-page":"463","article-title":"The effect of short-term prednisone treatment in adult nephrotics with minimal change (MC) and membranous (M) histology [abstract]","volume":"12","author":"Coggins","year":"1977","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0033|cit33","first-page":"237","article-title":"A randomised and controlled study to assess the effect of cyclosporin in nephrotic patients with membranous nephropathy and reduced renal function (CYCLOMEN)","volume":"7","author":"Laurens","year":"1994","journal-title":"Journal of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD004293.pub4-BIB0034|cit34","first-page":"95A","article-title":"Cyclosporine versus conservative therapy in patients with idiopathic membranous nephropathy (IMN) and deteriorating renal function: results of the CYCLOMEN trial [abstract no: A0514]","volume":"11","author":"Pisoni","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0035|cit35","unstructured":"Hirayama K Koyama A Randomized prospective trial of cyclosporine with\/without low-dose prednisolone in idiopathic membranous nephropathy in adults with nephrotic syndrome www.anzctr.org.au\/ACTRN12609000996268.aspx"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0036|cit36","first-page":"979","article-title":"Efficacy and safety of long-course tacrolimus treatment for idiopathic membranous nephropathy","volume":"16","author":"Di","year":"2018","journal-title":"Experimental & Therapeutic Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.1974.129","article-title":"Controlled trial of cyclophosphamide in idiopathic membranous nephropathy","volume":"6","author":"Donadio","year":"1974","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.ajkd.2008.04.013","article-title":"Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial","volume":"52","author":"Dussol","year":"2008","journal-title":"American Journal of Kidney Diseases"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0039|cit39","first-page":"566A","article-title":"Mycophenolate mofetil (MMF) in patients with idiopathic membranous nephropathy with nephrotic syndrome: a multicenter randomized trial [abstract no: TH-F-DS1092]","volume":"17","author":"Dussol","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0040|cit40","first-page":"A64","article-title":"Results of long-term randomised study of immunosuppressive treatment of patients with idiopathic membranous glomerulonephritis [abstract]","volume":"16","author":"Dyadyk","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-116-6-438","article-title":"Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network","volume":"116","author":"Falk","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0042|cit42","first-page":"270","article-title":"Mycophenolate mofetil combined with prednisone for treatment of idiopathic membranous nephropathy with nephrotic syndrome: a 36-month prospective controlled study","volume":"33","author":"Fu","year":"2012","journal-title":"Academic Journal of Second Military Medical University"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0044|cit44","first-page":"62A","article-title":"A randomized controlled trial of rituximab for severe idiopathic membranous nephropathy (IMN) [abstract no: SA-OR011]","volume":"26","author":"Ronco","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2017.01.012","article-title":"B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab","volume":"92","author":"Rosenzwajg","year":"2017","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 receptor 1 epitope spreading at baseline predicts reduced likelihood of remission of membranous nephropathy","volume":"29","author":"Seitz-Polski","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0047|cit47","first-page":"136","article-title":"Clinical advantage of concomitant use of low dose mizoribine and prednisolone on primary membranous nephropathy in the elderly [abstract no: TH-PO130]","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004293.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"iii509","DOI":"10.1093\/ndt\/gfx165.MP226","article-title":"Clinical advantage of concomitant use of mizoribine and prednisolone on primary membranous nephropathy in the elderly [abstract no: MP226]","volume":"32","author":"Hasegawa","year":"2017","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5301\/jn.5000199","article-title":"Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids","volume":"26","author":"He","year":"2013","journal-title":"Journal of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","article-title":"A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar R Gel) in nephrotic syndrome due to idiopathic membranous nephropathy","volume":"29","author":"Hladunewich","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0051|cit51","first-page":"58A","article-title":"A pilot study to determine dose, effectiveness and depletion of anti-PLA2R antibodies of adrencorticotrophic hormone (ACTH acthar gel) in subjects with nephrotic syndrome and idiopathic membranous nephropathy (iMN) [abstract no: FR-OR125]","volume":"23","author":"Hladunewich","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD004293.pub4-BIB0052|cit52","first-page":"668A","article-title":"Defining the optimal time of treatment start in patients with membranous nephropathy: a randomized study [abstract no: SU-PO969]","volume":"13","author":"Branten","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD004293.pub4-BIB0053|cit53","first-page":"341A","article-title":"Early versus late start of immunosuppressive therapy in patients with membranous nephropathy; a randomized study [abstract no: SA-PO188]","volume":"15","author":"Branten","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD004293.pub4-BIB0054|cit54","first-page":"60A","article-title":"No benefit of early start of immunosuppressive therapy in idiopathic membranous nephropathy [abstract no: F-FC264]","volume":"19","author":"Hofstra","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfp390","article-title":"Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial","volume":"25","author":"Hofstra","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9868","key":"10.1002\/14651858.CD004293.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial","volume":"381","author":"Howman","year":"2013","journal-title":"Lancet"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0057|cit57","first-page":"11A","article-title":"The UK randomized controlled trial of immunosuppression for progressive membranous nephropathy [abstract no: THOR048]","volume":"22","author":"Mathieson","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0058|cit58","first-page":"571","article-title":"Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results","volume":"27","author":"Imbasciati","year":"1980","journal-title":"Minerva Nefrologica"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0059|cit59","first-page":"717","article-title":"Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy","volume":"19","author":"Ponticelli","year":"1983","journal-title":"Proceedings of the European Dialysis & Transplant Association"},{"issue":"15","key":"10.1002\/14651858.CD004293.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"310","author":"Ponticelli","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0061|cit61","first-page":"554","article-title":"Controlled trial of monthly alternated courses of steroid and chlorambucil in idiopathic membranous nephropathy [abstract]","volume":"23","author":"Ponticelli","year":"1983","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0064|cit64","unstructured":"Ponticelli C Treatment of membranous nephropathy (MN) [abstract] 9th Asian Colloquium in Nephrology; 1992, May 17-21; Seoul, Korea 1992 22 4"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0065|cit65","unstructured":"Ponticelli C Treatment of membranous nephropathy [abstract] 12th International Congress of Nephrology; 1993, Jun 13-18; Jerusalem, Israel 1993 565"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0066|cit66","first-page":"282","article-title":"Clinical and morphologic evolution of idiopathic membranous nephropathy","volume":"25","author":"Zucchelli","year":"1986","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0067|cit67","first-page":"268","article-title":"Predictive indices of good prognosis in idiopathic membranous nephropathy [abstract]","volume":"28","author":"Zucchelli","year":"1985","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000167547","article-title":"Prognostic value of T lymphocyte subset ratio in idiopathic membranous nephropathy","volume":"8","author":"Zucchelli","year":"1988","journal-title":"American Journal of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","article-title":"A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy","volume":"18","author":"Jha","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0070|cit70","first-page":"A16","article-title":"A randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract no: FC3-02]","volume":"8","author":"Jha","year":"2003","journal-title":"Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0071|cit71","first-page":"213A","article-title":"Randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract no: A1100]","volume":"12","author":"Jha","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0072|cit72","unstructured":"Jha V Saha TK Kohli HS Sud K Gupta KL Joshi K A randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 114"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004293.pub4-BIB0073|cit73","first-page":"ii186","article-title":"Efficacy and safety of triple therapy with MMF, cyclosporine and prednisolone versus cyclosporine and prednisolone in adult patients with idiopathic membranous nephropathy and persistent heavy proteinuria [abstract no: FP347]","volume":"27","author":"Jurubita","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0074|cit74","first-page":"631","article-title":"Clinical evaluation of an immunosuppressive drug, mizoribine (HE-69) on steroid-resistant nephrotic syndrome. A multicenter double-blind comparison study with placebo","volume":"34","author":"Koshikawa","year":"1993","journal-title":"Jin ToTohseki [Kidney and Dialysis]"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/08860221003728754","article-title":"Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy","volume":"32","author":"Kosmadakis","year":"2010","journal-title":"Renal Failure"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4238\/2015.March.30.27","article-title":"Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy","volume":"14","author":"Li","year":"2015","journal-title":"Genetics & Molecular Research"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0077|cit77","first-page":"9764","article-title":"Comparison of efficacy and safety between tacrolimus and cyclosporine combined with corticosteroids in patients with idiopathic membranous nephropathy: a randomized controlled trial","volume":"10","author":"Li","year":"2017","journal-title":"International Journal of Clinical & Experimental Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/0886022X.2017.1325371","article-title":"The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy","volume":"39","author":"Liang","year":"2017","journal-title":"Renal Failure"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0079|cit79","first-page":"303","article-title":"Treatment of membranous nephropathy with Tripterygium wilfordii and steroid: a prospective randomized control trial","volume":"18","author":"Liu","year":"2009","journal-title":"Shenzangbing Yu Touxi Shenyizhi Zazhi [Chinese Journal of Nephrology Dialysis & Transplantation]"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD004293.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.hkjn.2015.09.019","article-title":"Clinical trial of treatment for idiopathic membranous nephropathy with leflunomide combined with cyclophosphamide and glucocorticoid [abstract]","volume":"17","author":"Liu","year":"2015","journal-title":"Hong Kong Journal of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0081|cit81","first-page":"851A","article-title":"Membranous nephropathy (MN): baseline health related quality of life (HRQOL) in patients with severe nephrotic syndrome (SNS) in the Membranous Nephropathy Trial of Rituximab (MENTOR) RCT [abstract no: SA-PO946]","volume":"27","author":"Beanlands","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa1814427","article-title":"Rituximab or cyclosporine in the treatment of membranous nephropathy","volume":"381","author":"Fervenza","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0083|cit83","first-page":"B2","article-title":"A multi-center randomized controlled trial of rituximab versus cyclosporine in the treatment of idiopathic membranous nephropathy (MENTOR) [abstract no: SA-OR127]","volume":"28","author":"Fervenza","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000430849","article-title":"A multicenter randomized controlled trial of rituximab versus cyclosporine in the treatment of idiopathic membranous nephropathy (MENTOR)","volume":"130","author":"Fervenza","year":"2015","journal-title":"Nephron"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0085|cit85","first-page":"229","article-title":"Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis","volume":"37","author":"Murphy","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopha.2010.10.009","article-title":"Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: a 3-year prospective study","volume":"65","author":"Naumovic","year":"2011","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12882-019-1539-z","article-title":"Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial","volume":"20","author":"Nikolopoulou","year":"2019","journal-title":"BMC Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0088|cit88","first-page":"385","article-title":"Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial [abstract no: TH-PO1021]","volume":"29","author":"Nikolopoulou","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0089|cit89","first-page":"e42473","article-title":"Comparison of the efficacy of tacrolimus versus cyclosporine in the treatment of idiopathic membranous nephropathy","volume":"9","author":"Omrani","year":"2017","journal-title":"Nephro-Urology Monthly"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0090|cit90","first-page":"350","article-title":"Prognosis and management of membraneous nephropathy","volume":"41","author":"Pahari","year":"1993","journal-title":"Journal of the Association of Physicians of India"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jfma.2015.07.021","article-title":"Comparison of different therapies in high-risk patients with idiopathic membranous nephropathy","volume":"115","author":"Peng","year":"2016","journal-title":"Journal of the Formosan Medical Association"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199208273270904","article-title":"Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group","volume":"327","author":"Ponticelli","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0093|cit93","unstructured":"Ponticelli C Treatment of idiopathic membranous nephropathy (IMN) [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 38"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0096|cit96","unstructured":"Praga M Barrio V Fernandez Juarez G Luno J Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial [abstract no: S-FC-010] 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil 2007 42"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney International"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0098|cit98","first-page":"63A","article-title":"Two year outcomes of patients with idiopathic membranous nephropathy, previously randomized to either modified Ponticelli regimen or to a combination of tacrolimus and steroids [abstract no: SA-OR012]","volume":"26","author":"Gupta","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0099|cit99","first-page":"S163","article-title":"Tacrolimus with oral prednisolone versus cyclical cyclophosphamide and steroids in primary membranous nephropathy: 5-year outcome of the randomised trial [abstract no: SUN-027]","volume":"4","author":"Kohli","year":"2019","journal-title":"Kidney International Reports"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/nep.12569","article-title":"Tacrolimus combined with corticosteroids versus modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial","volume":"21","author":"Ramachandran","year":"2016","journal-title":"Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0101|cit101","first-page":"62A","article-title":"Tacrolimus combined with corticosteroids versus modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial [abstract no: FR-OR066]","volume":"25","author":"Ramachandran","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004293.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"i77","DOI":"10.1093\/ndt\/gfw150.02","article-title":"Tacrolimus with corticosteroids is inferior to modified Ponticelli regimen in the management of primary membranous nephropathy: results at 2 years of randomization [abstract no: TO038]","volume":"31","author":"Ramachandran","year":"2016","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ekir.2017.02.004","article-title":"Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide","volume":"2","author":"Ramachandran","year":"2017","journal-title":"Kidney International Reports"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-121-5-199409010-00003","article-title":"Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide","volume":"121","author":"Reichert","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub4-BIB0105|cit105","first-page":"285","article-title":"Chlorambucil but not pulse cyclophosphamide reverses the deterioration of renal function in patients with membranous glomerulonephropathy [abstract no: 98P]","volume":"4","author":"Reichert","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004293.pub4-BIB0106|cit106","first-page":"615","article-title":"Ponticelli regime for membranous nephropathy - do Indians respond differently? [abstract no: W216]","volume":"18","author":"Gopal","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0107|cit107","first-page":"180","article-title":"Ponticelli regimen for membranous nephropathy - do Indians respond differently? [abstract]","volume":"12","author":"Sahay","year":"2002","journal-title":"Indian Journal of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10157-013-0925-2","article-title":"Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial","volume":"18","author":"Saito","year":"2014","journal-title":"Clinical & Experimental Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub4-BIB0109|cit109","first-page":"562A","article-title":"Effect of preprandial once-a-day administration of cyclosporine (CyA) for steroid resistant nephrotic syndrome (SRNS) [abstract no: SA-PO997]","volume":"18","author":"Saito","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0110|cit110","first-page":"634A","article-title":"Benefits of once-a-day preprandial administration and C2 monitoring for the cyclosporine (CyA) treatment of idiopathic membranous nephropathy (IMN) with steroid resistant nephrotic syndrome (SRNS) [abstract no: SA-PO2293]","volume":"20","author":"Saito","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0111|cit111","unstructured":"Saito T Watanabe M Ogahara S Shuto H Kataoka Y Significance of blood concentration of cyclosporine at 2 hours after administration for the treatment of idiopathic membranous nephropathy with steroid resistant nephrotic syndrome [abstract no: SA285] World Congress of Nephrology; 2009 May, 22-26; Milan, Italy 2009"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10157-016-1340-2","article-title":"Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome","volume":"21","author":"Saito","year":"2017","journal-title":"Clinical & Experimental Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004293.pub4-BIB0113|cit113","first-page":"iii430","article-title":"Effects of mizoribin combined with prednisolone for the treatment of idiopathic membranous nephropathy with steroid resistant nephrotic syndrome [abstract]","volume":"3","author":"Saito","year":"2010","journal-title":"NDT Plus"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ndt\/gfm538","article-title":"Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study","volume":"23","author":"Senthil Nayagam","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","article-title":"A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)","volume":"8","author":"Shibasaki","year":"2004","journal-title":"Clinical & Experimental Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub4-BIB0116|cit116","first-page":"1209","article-title":"Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis","volume":"115","author":"Western Canadian Glomerulonephritis Study Group","year":"1976","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0117|cit117","first-page":"606","volume-title":"European Union Biomedical and Health Research: the BIOMED 1 programme","volume":"1","author":"De Jong","year":"1995"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0118|cit118","first-page":"294","article-title":"ACE inhibition versus corticosteroids in membranous nephropathy (ACIMEN)","volume":"7","author":"Stegeman","year":"1994","journal-title":"Journal of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD004293.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11255-014-0801-3","article-title":"Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics","volume":"46","author":"Sun","year":"2014","journal-title":"International Urology & Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0120|cit120","unstructured":"Mathew TH The treatment of idiopathic glomerulonephritis Proceedings of the Second Asian Pacific Congress of Nephrology 1983 164 72"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0121|cit121","first-page":"603","article-title":"Australian glomerulonephritis trial: membranous glomerulonephritis, mesangiocapillary glomerulonephritis [abstract]","volume":"11","author":"Tiller","year":"1981","journal-title":"Australian & New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0122|cit122","first-page":"345","volume-title":"Advances in Basic and Clinical Nephrology. 8th International Congress of Nephrology; 1981 June 7-12; Athens, Greece","author":"Tiller","year":"1981"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004293.pub4-BIB0123|cit123","first-page":"43","article-title":"A double-blinded prospective randomised study on the efficacy of corticosteroid plus cyclophosphamide or FK506 in idiopathic membranous nephropathy patients with nephrotic syndrome [abstract no: FP05-05]","volume":"15","author":"Xu","year":"2010","journal-title":"Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004293.pub4-BIB0124|cit124","first-page":"iii431","article-title":"A double-blinded prospective randomised study on the efficacy of corticosteroid plus cyclophosphamide or FK506 in idiopathic membranous nephropathy patients with nephrotic syndrome [abstract no: SU364]","volume":"3","author":"Xu","year":"2010","journal-title":"NDT Plus"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000348475","article-title":"Tacrolimus combined with corticosteroids in idiopathic membranous nephropathy: a randomized, prospective, controlled trial","volume":"181","author":"Xu","year":"2013","journal-title":"Contributions to Nephrology"},{"issue":"5-6","key":"10.1002\/14651858.CD004293.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000348570","article-title":"Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome","volume":"91","author":"Yuan","year":"2013","journal-title":"Pharmacology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD004293.pub4-BIB0127|cit127","first-page":"S65","article-title":"Long-term efficacy and safety study of tacrolimus combined with corticosteroids in the treatment of idiopathic membranous nephropathy [abstract]","volume":"17","author":"Zhang","year":"2015","journal-title":"Hong Kong Journal of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1681\/ASN.V72290","article-title":"Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy","volume":"7","author":"Ambalavanan","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40261-013-0057-1","article-title":"Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: a 6-month placebo-controlled trial","volume":"33","author":"Badri","year":"2013","journal-title":"Clinical Drug Investigation"},{"issue":"5270","key":"10.1002\/14651858.CD004293.pub4-BIB0130|cit130","first-page":"412","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome","volume":"3","author":"Black","year":"1970","journal-title":"British Medical Journal"},{"issue":"Programs & Abst","key":"10.1002\/14651858.CD004293.pub4-BIB0131|cit131","first-page":"82A","article-title":"Cyclophosphamide is superior to chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency [abstract no: A0395]","volume":"8","author":"Branten","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/91.5.359","article-title":"Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency","volume":"91","author":"Branten","year":"1998","journal-title":"Qjm"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0133|cit133","unstructured":"Li W A prospective study of safety and efficacy in atypical membranous nephropathy by low-dose hormone combined immunosuppressive therapy www.chictr.org.cn\/showproj.aspx?proj=9713"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0134|cit134","unstructured":"Miao L Clinical studies of tacrolimus in idiopathic membranous nephropathy with nephrotic syndrome therapy www.chictr.org.cn\/showproj.aspx?proj=8996"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000415387","article-title":"Unconjugated hyperbilirubinemia due to ciclosporin administration in children with nephrotic syndrome","volume":"67","author":"Edefonti","year":"1988","journal-title":"Contributions to Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0136|cit136","first-page":"C8","article-title":"Unconjugated hyperbilirubinemia due to cyclosporin a (CyA) administration in children with nephrotic syndrome (NS) [abstract]","volume":"1","author":"Edefonti","year":"1987","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0137|cit137","unstructured":"Edefonti A Ghio L Rizzoni G Rinaldi S Gusmano R Lama G Cyclosporine (CSA) vs cyclophosphamide (CYC) for children with frequently relapsing\/steroid dependant nephrotic syndrome (FR\/SDNS): long term study [abstract] 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 - Sept 4; Jerusalem, Israel 1992 C70"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0138|cit138","first-page":"310","article-title":"Cyclosporine (CSA) vs cyclophosphamide (CYC) for children with frequently relapsing\/steroid dependent nephrotic syndrome (FR\/SDNS): long term study [abstract]","volume":"3","author":"Edefonti","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub4-BIB0139|cit139","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004293.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000168206","article-title":"Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis","volume":"10","author":"Ponticelli","year":"1990","journal-title":"American Journal of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0141|cit141","first-page":"147","article-title":"A multicenter controlled prospective trial with cyclosporine vs cyclophosphamide in frequent relapsers and steroid dependent patients with idiopathic nephrotic syndrome","volume":"2","author":"Ponticelli","year":"1989","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0142|cit142","unstructured":"Ponticelli C Ciclosporin in the treatment of idiopathic nephrotic syndrome [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 116"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1651-2227.1993.tb12723.x","article-title":"Renal effects of cyclosporin A in children treated for idiopathic nephrotic syndrome","volume":"82","author":"Tirelli","year":"1993","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0144|cit144","unstructured":"A 2 year study to investigate belimumab in membranous nephropathy www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2011-000242-38"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0145|cit145","unstructured":"Heimann JC Pestalozzi MS Praxedes JN Penna DO Saldanha LB Marcondes M Treatment of nephrotic syndrome: a prospective, double-blind study (prednisone vs placebo) [abstract] 10th International Congress of Nephrology; 1987 Jul 26-31; London, UK 1987 66"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0146|cit146","first-page":"14","article-title":"Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis","volume":"70","author":"Krasnova","year":"1998","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0147|cit147","unstructured":"Shilov EM Krasnova TN Ivanov AA Ivanova LV Shnyakina OV Tareyeva IE Oral cyclophosphamide versus cyclophosphamide (CPA) pulses in membranous and mesangial GN [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 116"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub4-BIB0148|cit148","first-page":"655","article-title":"Treatment with chlorambucil and azathioprine in primary glomerulonephritis. Results of a \"controlled\" study","volume":"81","author":"Lagrue","year":"1975","journal-title":"Journal d Urologie et de Nephrologie"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0149|cit149","first-page":"718A","article-title":"Tacrolimus in the treatment of HBV associated with membranous nephropathy: a prospective study [abstract no: SA-PO354]","volume":"23","author":"Li","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD004293.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3109\/0886022X.2016.1172917","article-title":"Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome","volume":"38","author":"Liu","year":"2016","journal-title":"Renal Failure"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0151|cit151","unstructured":"Majima K Hori Y Inoue T Ishizaki K Kinoshita E Nomura G The effects of treatment with prednisolone in patients with idiopathic membranous nephropathy [abstract] 11th International Congress of Nephrology; 1990, Jul 15-20; Tokyo, Japan 1990 117A"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0152|cit152","unstructured":"Michail S Filiopoulos V Kosmadakis G Tentolouris N Georgoulias C Gobou A Comparison of three regimens in patients with idiopathic membranous nephropathy (IMN) associated with nephrotic syndrome (NS) [abstract no: SP053] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004, May 15-18; Lisbon, Portugal 2004 34"},{"issue":"5756","key":"10.1002\/14651858.CD004293.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.2.5756.239","article-title":"Controlled trial of azathioprine and prednisone in chronic renal disease. Report by Medical Research Council Working Party","volume":"2","year":"1971","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0154|cit154","first-page":"163","article-title":"Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis","volume":"95","author":"Nand","year":"1997","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0155|cit155","unstructured":"Efficacy and safety study of intravenous belimumab versus placebo in subjects with idiopathic membranous nephropathy clinicaltrials.gov\/ct2\/show\/NCT01762852"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0156|cit156","unstructured":"Plavljanic D Spoljar-Scukanec M Milutinovic S Tubular damage in patients with membranous nephropathy. The response to treatment [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 193"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0158|cit158","first-page":"87","article-title":"Evaluation of immunosuppressive therapy in cases of steroid resistant idiopathic glomerulonephritis","volume":"22","author":"Sharma","year":"2009","journal-title":"Journal International Medical Sciences Academy"},{"issue":"656","key":"10.1002\/14651858.CD004293.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.2.5656.535","article-title":"Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine","volume":"2","author":"Sharpstone","year":"1969","journal-title":"British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub4-BIB0160|cit160","first-page":"542","article-title":"The effect of tacrolimus combined with small dose of hormone on idiopathic membranous nephropathy","volume":"28","author":"Sun","year":"2008","journal-title":"Zhongguo Shiyong Neike Zazhi [Chinese Journal of Practical Internal Medicine]"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1515\/CCLM.2011.168","article-title":"Treatment of hepatitis B virus-associated membranous nephritis patients in Chinese: an open parallel controlled trial","volume":"49","author":"Xu","year":"2011","journal-title":"Clinical Chemistry & Laboratory Medicine"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2016.04.017","article-title":"Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: an inspiration from a pilot trial","volume":"32","author":"Yang","year":"2016","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0163|cit163","unstructured":"Liu Z Tacrolimus treatment of patients with idiopathic membranous nephropathy clinicaltrials.gov\/ct2\/show\/NCT00302523"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0164|cit164","unstructured":"Liu Z To compare the efficacy and safety of Tripterygium wilfordii (TW) versus valsartan in the membranous nephropathy (MN) clinicaltrials.gov\/ct2\/show\/NCT00518219"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0165|cit165","unstructured":"Cattran D A dose escalation study of long-acting ACTH gel in membranous nephropathy clinicaltrials.gov\/ct2\/show\/NCT01093157"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0166|cit166","unstructured":"Acthar for treatment of proteinuria in membranous nephropathy patients (CHART) www.clinicaltrials.gov\/ct2\/show\/NCT01386554"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0167|cit167","unstructured":"Wang L Clinical study of QingReMoShen granule to treat idiopathic membranous nephropathy clinicaltrials.gov\/ct2\/show\/NCT01845688"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0168|cit168","first-page":"219","article-title":"Comparison of the efficacy and safety of tacrolimus monotherapy and cyclophosphamide combined with glucocorticoid in the treatment of adult primary membranous nephropathy: protocol of a multicenter, randomized, controlled, open study","volume":"21","author":"Chen","year":"2020","journal-title":"Trials [Electronic Resource]"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0169|cit169","unstructured":"Liu D Multitarget therapy for treatment of refractory idiopathic membranous nephropathy www.chictr.org.cn\/showproj.aspx?proj=12311"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0170|cit170","unstructured":"Liu Y The effect of the treatment of idiopathic membranous nephropathy was observed in the treatment of idiopathic membranous nephropathy, and the effect of the treatment on Th17 \/ Treg www.chictr.org.cn\/showproj.aspx?proj=19368"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0171|cit171","unstructured":"Shi W Yongquan acupoint Shenque moxibustion curative effect of traditional Chinese medicine in the treatment of membranous nephropathy www.chictr.org.cn\/showproj.aspx?proj=20524"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0172|cit172","unstructured":"Zhao M Use of sirolimus in patients with primary idiopathic membranous nephropathy: a prospective randomized control trial www.chictr.org.cn\/showproj.aspx?proj=20792"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0173|cit173","unstructured":"Su W A study for comparing alternating glucocorticoid and cyclophosphamide versus glucocorticoid plus tacrolimus in idiopathic membranous nephropathy www.chictr.org.cn\/showproj.aspx?proj=14061"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0174|cit174","unstructured":"Chen N Rituximab in the treatment of refractory membranous nephropathy: a multicenter, randomized, controlled clinical study www.chictr.org.cn\/showproj.aspx?proj=14456"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0175|cit175","unstructured":"Jiang Y Study on the effect and mechanism of interleukin -2 in the treatment of idiopathic membranous nephropathy www.chictr.org.cn\/showproj.aspx?proj=19215"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0176|cit176","unstructured":"Tu Y Compare of the treatment of membranous nephropathy with mizoribine and steroid or cyclophosphamide and steroid www.chictr.org.cn\/showproj.aspx?proj=18548"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0177|cit177","unstructured":"Zhang W A prospective randomized study on the efficacy of steroid combined with CTX or tacrolimus in IMN patients with NS www.chictr.org\/en\/proj\/show.aspx?proj=261"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0178|cit178","unstructured":"Ramachandran R Antibody targeted therapy in membranous nephropathy www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?trialid=18965"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0179|cit179","unstructured":"Randomized pilot study comparing tacrolimus vs. cyclophosphamide-prednisone in idiopathic membranous nephropathy - MEMTAC www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-005410-39\/ES"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0180|cit180","unstructured":"Matsuo S High-dose gamma-globulin therapy for nephrotic membranous nephropathy patients upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000007975"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0181|cit181","unstructured":"Zhao Z A randomized controlled study of tacrolimus for the treatment of idiopathic membranous nephropathy isrctn.com\/ISRCTN17977921"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0182|cit182","unstructured":"Berg AL Treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy www.isrctn.com\/ISRCTN70791258"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0183|cit183","unstructured":"Liang X Mycophenolate mofetil plus steroid in the treatment of patients with progressive idiopathic membranous nephropathy (MMF-STOP-IMN) clinicaltrials.gov\/ct2\/show\/NCT03170323"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0184|cit184","unstructured":"Deng Y A controlled study of steroids plus cyclosporin therapy for patients of idiopathic membranous nephropathy clinicaltrials.gov\/ct2\/show\/NCT02173106"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD004293.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"B9","DOI":"10.1681\/ASN.20203110S1B9a","article-title":"Rituximab vs cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO trial [abstract]","volume":"31","author":"Delbarba","year":"2020","journal-title":"Journal of the American Society of Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"e029232","DOI":"10.1136\/bmjopen-2019-029232","article-title":"Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial","volume":"9","author":"Scolari","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1681\/ASN.2020071091","article-title":"Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial","volume":"32","author":"Scolari","year":"2021","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ckj\/sfv075","article-title":"A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study","volume":"8","author":"Rojas-Rivera","year":"2015","journal-title":"Clinical Kidney Journal"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0189|cit189","unstructured":"Nakanishi T Optimal use of ciclosporin in membranous nephropathy (OCIM-NS study) upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000001321"},{"issue":"11","key":"10.1002\/14651858.CD004293.pub4-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/jcp.39.11.1193","article-title":"Idiopathic membranous glomerulonephritis: aspects of geographical differences","volume":"39","author":"Abe","year":"1986","journal-title":"Journal of Clinical Pathology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Bonegio","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub4-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: the CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1523-1755.1999.00675.x","article-title":"Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy","volume":"56","author":"Berg","year":"1999","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0194|cit194","first-page":"198","article-title":"Hepatitis B virus-associated nephropathy","volume":"24","author":"Bhimma","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2215\/CJN.05231008","article-title":"Rituximab therapy for membranous nephropathy: asystematic review","volume":"4","author":"Bomback","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DDDT.S17521","article-title":"Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel","volume":"5","author":"Bomback","year":"2011","journal-title":"Drug Design, Development & Therapy"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0197|cit197","doi-asserted-by":"crossref","unstructured":"Bullich G Ballarin J Oliver A Ayasreh N Silva I Santin S HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy Clinical Journal of The American Society of Nephrology: CJASN 2014 9 2 335 43 24262501","DOI":"10.2215\/CJN.05310513"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0198|cit198","first-page":"319","article-title":"Nephrotic syndrome in the elderly","volume":"16","author":"Cameron","year":"1996","journal-title":"Seminars in Nephrology"},{"issue":"9205","key":"10.1002\/14651858.CD004293.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(05)72172-3","article-title":"The QUORUM statement","volume":"355","author":"Clarke","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/9.5.469","article-title":"Treatment of membranous nephropathy: a meta-analysis","volume":"9","author":"Couchoud","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0201|cit201","first-page":"211","article-title":"Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy","volume":"57","author":"Deegens","year":"2005","journal-title":"Minerva Urologica e Nefrologica"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2005.08.020","article-title":"Idiopathic membranous nephropathy: outline and rationale of a treatment strategy","volume":"46","author":"du Buf-Vereijken","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"14","key":"10.1002\/14651858.CD004293.pub4-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM197609302951401","article-title":"Treatment of idiopathic membranous nephropathy","volume":"295","author":"Ehrenreich","year":"1976","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ckj\/sfw091","article-title":"Treatment with rituximab in idiopathic membranous nephropathy","volume":"9","author":"Fiorentino","year":"2016","journal-title":"Clinical Kidney Journal"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1053\/j.ajkd.2015.07.006","article-title":"AJKD atlas of renal pathology: membranous nephropathy","volume":"66","author":"Fogo","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"7650","key":"10.1002\/14651858.CD004293.pub4-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/1536867X0900900202","article-title":"Updated tests for small-study effects in meta-analyses","volume":"9","author":"Harbord","year":"2009","journal-title":"Stata Journal"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-100-24736","article-title":"Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions","volume":"100","author":"Heymann","year":"1959","journal-title":"Proceedings of the Society for Experimental Biology & Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD004293.pub4-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0211|cit211","unstructured":"Higgins JPT Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ndt\/gfr371","article-title":"Management of patients with membranous nephropathy","volume":"27","author":"Hofstra","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub4-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Medical Research Methodology"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub4-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V581553","article-title":"Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials","volume":"5","author":"Imperiale","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0216|cit216","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Guideline Work Group 2020 Clinical Practice Guidelines on Glomerular Diseases www.kdigo.org\/guidelines\/gn\/ 2020 Public review"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ckj\/sfw045","article-title":"Efficacy and safety of adrenocorticotropic hormone treatment in glomerular diseases: a systematic review and meta-analysis","volume":"9","author":"Kittanamongkolchai","year":"2016","journal-title":"Clinical Kidney Journal"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0218|cit218","doi-asserted-by":"crossref","unstructured":"Lai FM To KF Choi PC Szeto CC Li PK Hepatitis B virus-related nephropathy and lupus nephritis: morphologic similarities of two clinical entities Modern Pathology 2000 13 2 166 72 10697274","DOI":"10.1038\/modpathol.3880031"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub4-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jfma.2014.11.002","article-title":"Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment","volume":"114","author":"Lai","year":"2015","journal-title":"Journal of the Formosan Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0220|cit220","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003965.pub3","article-title":"Immunosuppressive agents for treating IgA nephropathy","author":"Natale","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0221|cit221","doi-asserted-by":"crossref","unstructured":"Polanco N Gutierrez E Covarsi A Ariza F Carreno A Vigil A Baltar J Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy Journal of the American Society of Nephrology 2010 21 4 697 704 20110379","DOI":"10.1681\/ASN.2009080861"},{"issue":"13","key":"10.1002\/14651858.CD004293.pub4-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1517\/14656566.2010.494599","article-title":"Management of idiopathic membranous nephropathy","volume":"11","author":"Ponticelli","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9337","key":"10.1002\/14651858.CD004293.pub4-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2215\/CJN.01080905","article-title":"Rituximab for idiopathic membranous nephropathy: who can benefit?","volume":"1","author":"Ruggenenti","year":"2006","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0225|cit225","doi-asserted-by":"crossref","unstructured":"Ruggenenti P Cravedi P Chianca A Perna A Ruggiero B Gaspari F Rambaldi A Maras\u00e0 M Remuzzi G Rituximab in Idiopathic Membranous Nephropathy Journal of the AMerican Society of Nephrology: JASN 23 1416 1425 22822077","DOI":"10.1681\/ASN.2012020181"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0226|cit226","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0227|cit227","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Deeks JJ Glasziou P Guyatt GH Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub4-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004293.pub4-BIB0229|cit229","doi-asserted-by":"crossref","unstructured":"Tomas NM Meyer-Schwesinger C Seitz-Polski B Hong M Zahner G Dolla G Hoxha E Helmchen U Dabert-Gay AS Debayle D Merchant M Klein J Salant DJ Stahl RAK Lambeau G Thrombospondin- type-1-domain-containing 7A in idiopathic membranous nephropathy New England Journal of Medicine: NEJM 371 24 2277 2287 25394321","DOI":"10.1056\/NEJMoa1409354"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub4-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1681\/ASN.2005101144","article-title":"Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis","volume":"17","author":"Tramontano","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2018.07.008","article-title":"Immunosuppressive treatment for proliferative lupus nephritis: summary of a Cochrane review","volume":"72","author":"Tunnicliffe","year":"2018","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0232|cit232","first-page":"340","article-title":"Epidemiology of primary glomerulonephritis in the elderly. Report from the Italian Registry of Renal Biopsy","volume":"14","author":"Vendemia","year":"2001","journal-title":"Journal of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub4-BIB0233|cit233","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneph.2009.101","article-title":"Controversies in the treatment of idiopathic membranous nephropathy","volume":"5","author":"Waldman","year":"2009","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub4-BIB0234|cit234","first-page":"9","article-title":"Therapy of rituximab in idiopathic membranous nephropathy with nephrotic syndrome: asystematic review and meta-analysis","volume":"33","author":"Zou","year":"2018","journal-title":"Chinese Medical Sciences Journal"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub4-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2215\/CJN.07570712","article-title":"Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials","volume":"8","author":"Chen","year":"2013","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"10","key":"10.1002\/14651858.CD004293.pub4-BIB0236|cit236","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004293.pub3","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome","author":"Chen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub4-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0272-6386(04)00809-1","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review","volume":"44","author":"Perna","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub4-BIB0238|cit238","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004293.pub2","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome","author":"Schieppati","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:40:48Z","timestamp":1726116048000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004293.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":238,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004293.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}